Jonathan Sheena - Feb 26, 2025 Form 4 Insider Report for Natera, Inc. (NTRA)

Signature
/s/ Tami Chen, Attorney-in-Fact
Stock symbol
NTRA
Transactions as of
Feb 26, 2025
Transactions value $
-$914,873
Form type
4
Date filed
2/28/2025, 09:05 PM
Previous filing
Feb 4, 2025
Next filing
Mar 14, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Sale -$7.79K -50 -0.02% $155.81 263K Feb 26, 2025 Direct F1
transaction NTRA Common Stock Sale -$31.6K -200 -0.08% $157.80 263K Feb 26, 2025 Direct F1, F2
transaction NTRA Common Stock Sale -$92.4K -580 -0.22% $159.24 263K Feb 26, 2025 Direct F1, F3
transaction NTRA Common Stock Sale -$206K -1.28K -0.49% $161.04 261K Feb 26, 2025 Direct F1, F4
transaction NTRA Common Stock Sale -$95.6K -590 -0.23% $162.06 261K Feb 26, 2025 Direct F1, F5
transaction NTRA Common Stock Sale -$9.96K -64 -0.14% $155.66 44.7K Feb 26, 2025 By Caraluna 1 Trust F6, F7
transaction NTRA Common Stock Sale -$47K -296 -0.66% $158.77 44.4K Feb 26, 2025 By Caraluna 1 Trust F6, F7, F8
transaction NTRA Common Stock Sale -$113K -704 -1.58% $160.76 43.7K Feb 26, 2025 By Caraluna 1 Trust F6, F7, F9
transaction NTRA Common Stock Sale -$54.3K -336 -0.77% $161.58 43.4K Feb 26, 2025 By Caraluna 1 Trust F6, F7, F10
transaction NTRA Common Stock Sale -$16.3K -100 -0.23% $162.64 43.3K Feb 26, 2025 By Caraluna 1 Trust F6, F7
transaction NTRA Common Stock Sale -$11.2K -72 -0.16% $155.66 44.7K Feb 26, 2025 By Caraluna 2 Trust F6, F7
transaction NTRA Common Stock Sale -$46.4K -292 -0.65% $158.88 44.4K Feb 26, 2025 By Caraluna 2 Trust F6, F7, F11
transaction NTRA Common Stock Sale -$120K -744 -1.67% $160.85 43.7K Feb 26, 2025 By Caraluna 2 Trust F6, F7, F12
transaction NTRA Common Stock Sale -$47.8K -296 -0.68% $161.64 43.4K Feb 26, 2025 By Caraluna 2 Trust F6, F7, F13
transaction NTRA Common Stock Sale -$15.6K -96 -0.22% $162.64 43.3K Feb 26, 2025 By Caraluna 2 Trust F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.
F2 These shares were sold in multiple transactions at prices ranging from $157.4150 to $158.1900 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
F3 These shares were sold in multiple transactions at prices ranging from $158.72 to $159.58 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
F4 These shares were sold in multiple transactions at prices ranging from $160.5300 to $161.4450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
F5 These shares were sold in multiple transactions at prices ranging from $161.64 to $162.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
F6 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
F7 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
F8 These shares were sold in multiple transactions at prices ranging from $158.33 to $159.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
F9 These shares were sold in multiple transactions at prices ranging from $160.2550 to $161.2500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
F10 These shares were sold in multiple transactions at prices ranging from $161.29 to $161.83 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
F11 These shares were sold in multiple transactions at prices ranging from $158.6850 to $159.2500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
F12 These shares were sold in multiple transactions at prices ranging from $160.43 to $161.29 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
F13 These shares were sold in multiple transactions at prices ranging from $161.4750 to $161.8200 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote